Literature DB >> 1082491

T-lymphocyte-enriched murine peritoneal exudate cells. II. Genetic control of antigen-induced T-lymphocyte proliferation.

R H Schwartz, W E Paul.   

Abstract

The recent introduction of a reliable, T-lymphocyte proliferation assay, which utilizes thioglycollate-induced, nylon wool column-passed, peritoneal exudate lymphocytes from immune mice (PETLES), allowed us to investigate the genetic control of murine immune responses at the T-lymphocyte level. Examination of the blast cells generated in this population 5 days after stimulation with antigen, revealed that 85% of the cells bore the Thy 1 antigen on their surface, whereas only 5% bore immunoglobulin. Thus, the assay can be considered to measure almost exclusively T-lymphocyte function. This assay was used to examine the T-lymphocyte proliferative responses to seven different antigens: poly(Glu60Ala30Tyr10), poly(Glu58Lys38Tyr4), poly-(Tyr,Glu)-poly-D,L-Ala--poly-Lys, poly-(Phe,Glu)-poly-D,L-Ala--poly-Lys, staphylococcal nuclease, lactate dehydrogenase H4, and the BALB/c IgA myeloma protein, TEPC-15. PETLES from a large number of different inbred mouse strains, including H-2 congenic resistant lines and H-2 recombinants, were studied. The strains could be classified as high responders, low responders, or nonresponders to a particular antigen as judged by the magnitude of the T-lymphocyte proliferative response. In every case but one this classification corresponded to the responder status given the strain based on its ability to mount an in vivo antibody response to the same antigen. For two of the antigens, poly-(Tyr,Glu)-poly-D,L-Ala--poly-Lys and TEPC-15, the immune response genes controlling the T-lymphocyte proliferative response were mapped to the K region or I-A subregion of the major histocompatibility complex, as had previously been shown for the control of the antibody responses to these antigens. This tight linkage of the two phenotypic responses very strongly suggests that the same immune response gene controls the expression of both the proliferative and antibody responses. Since there is essentially no contribution from B lymphocytes in the T-lymphocyte proliferation assay, it seems reasonable to conclude that none of the seven immune response genes studied are expressed solely in B lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1082491      PMCID: PMC2190148          DOI: 10.1084/jem.143.3.529

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Synthesis and chemical properties of poly-alpha-amino acids.

Authors:  E KATCHALSKI; M SELA
Journal:  Adv Protein Chem       Date:  1958

2.  Immune responses in vitro. I. Culture conditions for antibody synthesis.

Authors:  R E Click; L Benck; B J Alter
Journal:  Cell Immunol       Date:  1972-02       Impact factor: 4.868

3.  Affinity labeling of a phosphorylcholine binding mouse myeloma protein.

Authors:  B Chesebro; H Metzger
Journal:  Biochemistry       Date:  1972-02-29       Impact factor: 3.162

4.  Two genes in the major histocompatibility complex control immune response.

Authors:  A J Munro; M J Taussig
Journal:  Nature       Date:  1975-07-10       Impact factor: 49.962

Review 5.  The histocompatibility-linked immune response genes.

Authors:  B Benacerraf; D H Katz
Journal:  Adv Cancer Res       Date:  1975       Impact factor: 6.242

6.  Histocompatibility-linked immune response gene function in guinea pigs. Specific inhibition of antigen-induced lymphocyte proliferation by alloantisera.

Authors:  E M Shevach; W E Paul; I Green
Journal:  J Exp Med       Date:  1972-11-01       Impact factor: 14.307

7.  The role of thymus cells in the immune response to poly(Tyr, Glu)-polyD L Ala--polyLys as a function of the genetic constitution of the mouse strain.

Authors:  L Lichtenberg; E Mozes; G M Shearer; M Sela
Journal:  Eur J Immunol       Date:  1974-06       Impact factor: 5.532

8.  Genetic control of the immune response. Mapping of the Ir-1 locus.

Authors:  H O McDevitt; B D Deak; D C Shreffler; J Klein; J H Stimpfling; G D Snell
Journal:  J Exp Med       Date:  1972-06-01       Impact factor: 14.307

9.  Genetic control of the immune response: in vitro stimulation of lymphocytes by (T,G)-A--L, (H,G)-A--L, and (Phe,G)-A--L.

Authors:  P Lonai; H O McDevitt
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

10.  THE AKR THYMIC ANTIGEN AND ITS DISTRIBUTION IN LEUKEMIAS AND NERVOUS TISSUES.

Authors:  A E REIF; J M ALLEN
Journal:  J Exp Med       Date:  1964-09-01       Impact factor: 14.307

View more
  38 in total

1.  Immune response gene control of the mouse antibody responses to human creatine kinase-MM and the lactate dehydrogenase-1 enzymes.

Authors:  V Hauptfeld-Dolejsek; H C Vaidya; D C Shreffler
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

2.  Mechanisms of genetic control of immune responses. II. Nonresponsiveness in BALB/c GT-specific cell-mediated immune responses does not correlate with the absence of functional T cells or the induction of suppressor T cells.

Authors:  M K Kennedy; M K Jenkins; S D Miller
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

Review 3.  Regulatory mechanisms of antitumor T cell responses in the tumor-bearing state.

Authors:  H Fujiwara; T Hamaoka
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

4.  T-lymphocyte response to cytochrome c. I. Demonstration of a T-cell heteroclitic proliferative response and identification of a topographic antigenic determinant on pigeon cytochrome c whose immune recognition requires two complementing major histocompatibility complex-linked immune response genes.

Authors:  A M Solinger; M E Ultee; E Margoliash; R H Schwartz
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

5.  Inhibition of dual Ir gene-controlled T-lymphocyte proliferative response to poly (Glu56Lys35Phe9)n with anti-Ia antisera directed against products of either I-A or I-C subregion.

Authors:  R H Schwartz; C S David; M E Dorf; B Benacerraf; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

6.  Genetic control of the proliferative response to oxazolone in H-2 congenic and recombinant strains of mice.

Authors:  Z Bösze; J Fachet
Journal:  Immunology       Date:  1979-12       Impact factor: 7.397

7.  Antigen-specific HLA-restricted human T-cell lines. I. An MT3-like restriction determinant distinct from HLA-DR.

Authors:  E J Ball; P Stastny
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

8.  Stimulation of rat autologous mixed lymphocyte reaction with xenogeneic sera and their protein preparations.

Authors:  N Endho; M Chiba; Y Hashimoto
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

9.  In vitro responses to the liver antigen F.

Authors:  G H Sunshine; M Cyrus; G Winchester
Journal:  Immunology       Date:  1982-02       Impact factor: 7.397

10.  Antigen-specific human T-cell clones: development of clones requiring HLA-DR-compatible presenting cells for stimulation in presence of antigen.

Authors:  B Sredni; D Volkman; R H Schwartz; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.